CompoAtlas

LEVLA

LEVLA, licence 80142742: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

Natural health product licensed in Canada

Licence holder
DMG Services Inc
NPN or DIN-HM
80142742
Status
Active licence
Licence date
17 July 2025
Revision date
11 May 2026
Form
Capsule
Route of administration
Orale
Application type
Générale (non traditionelle)

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Lepidium meyenii

Source : Lepidium meyenii - racine

Extract : Matériel brut sec

Extraction ratio : 20.000:1

Dry plant equivalent : 1500 mg

75.0 mgNot calculated
Tribulus terrestris

Source : Tribulus terrestris - Fruit

Extract : Matériel brut sec

Extraction ratio : 10.000:1

Dry plant equivalent : 1500 mg

150.0 mgNot calculated
Panax ginseng

Source : Panax ginseng - racine

Extract : Matériel brut sec

Extraction ratio : 10.000:1

Dry plant equivalent : 1500 mg

150.0 mgNot calculated
Capsicum annuum

Source : Capsicum annuum - fruit

20.0 mgNot calculated

Non-medicinal ingredients

Gélatine, Bleu FD&C n° 1, Stéarate de magnésium, Cellulose microcristalline, Dioxyde de titane, Maltodextrine

PopulationAgeQuantity per servingFrequency
Adultesminimum: 18.0 Année(s)2.0 Capsule1.0 Tous les jours

Uses authorised in Canada

Aide à soutenir les aspects émotionnels de la santé sexuelle. Aide à soutenir un équilibre sain de l'humeur durant la ménopause. (Utilisé en phytothérapie pour) aide(r) à accroître les capacités physiques/la performance physique (dans les cas de stress physique). Utilisé en phytothérapie/herboristerie comme adaptogène pour aider à accroître l'énergie et la résistance au stress (par. ex., dans les cas de fatigue mentale ou physique liées au stress). Tribulus terrestris est utilisé traditionnellement en Ayurveda comme Vrsya aphrodisiaque pour les hommes. Capsicum annuum est utilisé traditionnellement en phytothérapie pour aider à contribuer au maintien de la circulation périphérique.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80142742

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line